NGM Biopharmaceuticals Inc. Stock News

By David Bautz, PhD NASDAQ:VKTX READ THE FULL VKTX RESEARCH REPORT Business Update Podium Presentation at EASL On February 26, 2020, Viking Therapeutics, Inc. (NASDAQ:VKTX) announced that an abstract

The Zacks Analyst Blog Highlights: Moderna, Incyte, Heron Therapeutics and NGM Biopharmaceuticals

The Zacks Analyst Blog Highlights: Moderna, Incyte, Heron Therapeutics and NGM Biopharmaceuticals

The biotech sector was in focus with pipeline updates from a few small biotech companies.

Stifel Nicolaus raised Home Depot Inc (NYSE: HD) price target from $245 to $270. Home Depot closed at $237.38 on Tuesday. Raymond James boosted the price target for salesforce...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Brainst

SOUTH SAN FRANCISCO, Calif., Feb. 25, 2020 -- NGM Biopharmaceuticals, Inc. (Nasdaq: NGM), a biotechnology company focused on developing transformative therapeutics for.

In what looks to be a transformative year for potential treatments of nonalcoholic steatohepatitis, the liver disease better known as NASH, another

A WHO official calls Gilead's drug the best current chance for a drug to help people infected with the coronavirus Covid-19, sending the Foster City-based company's stock upwards.

Fly Intel: Wall Street's top stories at midday UNH AAPL NKE GILD BRK.A DAL AAL JBLU LUV UAL INTU NGM VHC KOS EPZM

NGM Biopharmaceuticals (NASDAQ:NGM) +67% after aldafermin phase 2 results.NanoViricides (NYSEMKT:NNVC) +39% on drugmakers working on coronavirus.Enlivex Therapeutics (NASDAQ:ENLV) +37% after disclo

NGM Biopharmaceuticals, Inc. (NGM), a biotechnology company focused on developing transformative therapeutics for patients, today announced positive preliminary topline results from the 24-week double

SOUTH SAN FRANCISCO, Calif., Feb. 23, 2020 -- NGM Biopharmaceuticals, Inc. (Nasdaq: NGM) will host a conference call and live webcast on Monday, February 24, 2020 at 8:30 a.m..

Although the first wave (the companies with drugs at Phase-3) is already at the finish line, the effectiveness indicators of these drugs are far from being stro

Tables of the top insider purchases and sales filed with the SEC on 2/10/20, based on dollar value. Dollar values often do not equate with significance when it